|
ANKRD27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.27699997640474E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24040000493153E-09 |
| Normal-vs-Stage2 |
1.61917000000011E-05 |
| Normal-vs-Stage3 |
1.120030E-02 |
| Normal-vs-Stage4 |
4.670400E-02 |
| Stage1-vs-Stage2 |
6.410000E-01 |
| Stage1-vs-Stage3 |
1.584450E-01 |
| Stage1-vs-Stage4 |
6.503000E-01 |
| Stage2-vs-Stage3 |
3.212200E-01 |
| Stage2-vs-Stage4 |
7.815400E-01 |
| Stage3-vs-Stage4 |
6.381400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.9553999792451E-09 |
| Normal-vs-AfricanAmerican |
1.814040E-04 |
| Normal-vs-Asian |
4.397000E-01 |
| Caucasian-vs-AfricanAmerican |
6.712400E-01 |
| Caucasian-vs-Asian |
4.161200E-01 |
| AfricanAmerican-vs-Asian |
5.233400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.65210084396494E-11 |
| Normal-vs-Female |
5.982400E-02 |
| Male-vs-Female |
8.997400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.83320000002318E-06 |
| Normal-vs-Extreme_Weight |
3.45109496535656E-11 |
| Normal-vs-Obese |
9.036400E-04 |
| Normal-vs-Extreme_Obese |
1.687990E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.948000E-01 |
| Normal_Weight-vs-Obese |
1.803160E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.061200E-01 |
| Extreme_Weight-vs-Obese |
3.284400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.564200E-01 |
| Obese-vs-Extreme_Obese |
5.069200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.329800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.05649999999169E-05 |
| Normal-vs-Age(61-80Yrs) |
5.96209970282757E-10 |
| Normal-vs-Age(81-100Yrs) |
3.951600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.492200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.223700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.039600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.389800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.030600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.475200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.55789944780815E-10 |
| Normal-VS-Type2 PRCC |
2.02309999999262E-05 |
| Normal-VS-KIRP CIMP |
8.849400E-01 |
| Normal-VS-Unclassified PRCC |
3.502200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.442400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.804100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.361150E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.106300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.861000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.292600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.70029999974264E-07 |
| Normal-vs-N1 |
8.212600E-01 |
| Normal-vs-N2 |
2.245600E-04 |
| N0-vs-N1 |
1.213990E-02 |
| N0-vs-N2 |
5.094800E-01 |
| N1-vs-N2 |
1.163600E-01 |
|
|
